BIO Professional Development

Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth

02/27/2024  -  02/27/2024  |  8:30 AM  -  4:00 PM  EST

Commercialization Readiness from Preclinical to 1st Launch

Commercialization Readiness from Preclinical to 1st Launch: The First Time CEO’s Playbook will equip early-stage biotechnology leaders with the commercialization knowledge they need to strategically position their organizations for financing success and meeting critical commercial milestones. 

The drug development process is complex and multifaceted, and understanding the commercialization considerations at each phase is vital. From preclinical to first product launch, this one-day course will help biotech executives make informed strategic choices for long-term success.  

This interactive course will cover phase-specific market analysis, including a competitive landscape assessment, regulatory considerations, the Commercialization Roadmap development, FTEs and dollar spend, market access pricing and reimbursement, value proposition development, and go-to-market preparation. 

Russ Belden, founder and CEO of Bridge, will guide you through this course by sharing real-world examples and valuable insights. Russ is a biotech commercialization leader with over 36 years of senior operational experience in the preclinical to first launch space.  

Developed by Biotech Primer, BIO’s official education partner, Commercialization Readiness: From Phase 1 to 1st Launch will empower you to navigate the commercialization journey effectively.

This one-day course will be held in person on Tuesday, February 27, 2024, in New York City, N.Y. Please note that this course runs concurrently with sessions in the BIO CEO & Investor Conference program.

Takeaways

  • Commercial imperatives that impact value: Preclinical -- Phase I
  • Commercial and medical affairs imperatives: Phase II -- Phase III
  • Commercial and medical affairs imperatives: Positive data readout to launch
  • Medical affairs imperatives
  • Life cycle management

Download Course Syllabus

Agenda: Commercialization Readiness from Preclinical to 1st Launch Course
Course Price:
$2,300 USD
BIO Member Price:
$1,900 USD
Course Length:
One-day (February 27, 2024, 2023: New York, N.Y.)
Course Level:
Introductory
Completion Period:
February 27, 2024
Course Format:
In Person

Certificate Requirements

  • Attend the entire in-person course
  • Complete course evaluation within two weeks of the course end date
Related Courses
FLIP

A digital strategy can no longer lie within a siloed digital or innovation team. It’s critical to integrate digital across the enterprise to maintain a competitive edge.

FLIP

A good regulatory strategy is essential to a good business strategy.

Professional Certificate
FLIP

Take your next step to ensure that the field of digital health is worthy of our trust.

FLIP

Learn the core elements of revenue forecasting.

Professional Certificate